To me this could be a sign of things to come. Sales beginning to get some traction. I have bought back in. At less than 4 cents I consider it good value, with limited downside risk. But DYOR.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025